Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice

Kelly A. Loffler, Christine A. Biondi, Michael G. Gartside, Magdalena M.M. Serewko-Auret, Russell Duncan, Ian D. Tonks, Arne Mould, Paul M. Waring, Hans Konrad Muller, Graham F. Kay, Nicholas Kim Hayward

Research output: Contribution to journalArticle

22 Citations (Scopus)

Abstract

To identify possible genetic interactions between the mechanisms of tumor suppression of menin and pRb, we intercrossed mice with targeted deletions of Men1 and Rb1, and compared tumor development in cohorts of animals carrying single or dual mutations of these tumor-suppressor genes. In mice lacking one copy of Men1, pancreatic islet and anterior pituitary adenomas are common. In animals lacking one copy of Rb1, intermediate pituitary and thyroid tumors occur at high frequency, with less frequent development of pancreatic islet hyperplasia and parathyroid lesions. In mice heterozygous for both Men1 and Rb1, pancreatic hyperplasia and tumors of the intermediate pituitary and thyroid occurred at high frequency. Serum measurements of calcium and glucose did not vary significantly between genotypic groups. Loss of heterozygosity at the Rb1 locus was common in pituitary and thyroid tumors, whereas loss of menin was observed in pancreatic and parathyroid lesions. The tumor spectrum in the double heterozygotes was a combination of pathologies seen in each of the individual heterozygotes, without decrease in age of onset, indicating independent, non-additive effects of the two mutations. Together with the lack of increased tumor spectrum, this suggests that menin and pRb function in a common pathway of tumor suppression.
Original languageEnglish
Pages (from-to)4009-4017
Number of pages9
JournalOncogene
Volume26
Issue number27
DOIs
Publication statusPublished - 7 Jun 2007
Externally publishedYes

Keywords

  • endocrine
  • pancreas
  • pituitary
  • parathyroid
  • thyroid

Fingerprint Dive into the research topics of 'Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice'. Together they form a unique fingerprint.

  • Cite this

    Loffler, K. A., Biondi, C. A., Gartside, M. G., Serewko-Auret, M. M. M., Duncan, R., Tonks, I. D., Mould, A., Waring, P. M., Muller, H. K., Kay, G. F., & Hayward, N. K. (2007). Lack of augmentation of tumor spectrum or severity in dual heterozygous Men1 and Rb1 knockout mice. Oncogene, 26(27), 4009-4017. https://doi.org/10.1038/sj.onc.1210163